(0.08%) 5 331.50 points
(0.01%) 40 143 points
(0.13%) 18 660 points
(-0.05%) $80.02
(0.88%) $2.65
(1.10%) $2 443.90
(2.91%) $32.17
(0.29%) $1 093.20
(-0.01%) $0.920
(-0.02%) $10.67
(0.05%) $0.787
(-0.25%) $90.75
Live Chart Being Loaded With Signals
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide...
Stats | |
---|---|
Today's Volume | 1.39M |
Average Volume | 1.35M |
Market Cap | 227.24B |
EPS | $0 ( 2024-04-24 ) |
Next earnings date | ( $5.13 ) 2024-07-24 |
Last Dividend | $0.350 ( 2023-12-14 ) |
Next Dividend | $0 ( N/A ) |
P/E | 38.16 |
ATR14 | $0.256 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-14 | Lagarde Michel | Sell | 20 000 | Stock Option (Right to Buy) |
2024-05-14 | Lagarde Michel | Buy | 20 000 | Common Stock |
2024-05-14 | Lagarde Michel | Sell | 20 000 | Common Stock |
2024-05-13 | Williamson Stephen | Buy | 21 925 | Common Stock |
2024-05-13 | Williamson Stephen | Sell | 21 925 | Common Stock |
INSIDER POWER |
---|
-56.66 |
Last 98 transactions |
Buy: 106 888 | Sell: 387 838 |
Volume Correlation
Thermo Fisher Scientific Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Thermo Fisher Scientific Correlation - Currency/Commodity
Thermo Fisher Scientific Financials
Annual | 2023 |
Revenue: | $42.86B |
Gross Profit: | $15.22B (35.52 %) |
EPS: | $15.53 |
FY | 2023 |
Revenue: | $42.86B |
Gross Profit: | $15.22B (35.52 %) |
EPS: | $15.53 |
FY | 2022 |
Revenue: | $44.92B |
Gross Profit: | $19.50B (43.42 %) |
EPS: | $17.73 |
FY | 2021 |
Revenue: | $39.21B |
Gross Profit: | $19.64B (50.08 %) |
EPS: | $19.62 |
Financial Reports:
No articles found.
Thermo Fisher Scientific Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.350 (N/A) |
$0.350 (N/A) |
$0.350 (N/A) |
$0.350 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0430 | 1993-08-06 |
Last Dividend | $0.350 | 2023-12-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-16 | |
Next Payout Date | N/A | |
# dividends | 52 | -- |
Total Paid Out | $12.89 | -- |
Avg. Dividend % Per Year | 0.15% | -- |
Score | 4.62 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.07 | |
Div. Directional Score | 8.46 | -- |
Year | Amount | Yield |
---|---|---|
1993 | $0.0430 | 0.31% |
1994 | $0 | 0.00% |
1995 | $0 | 0.00% |
1996 | $0.00400 | 0.01% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $3.34 | 11.50% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0.540 | 1.15% |
2013 | $0.600 | 0.92% |
2014 | $0.600 | 0.55% |
2015 | $0.600 | 0.47% |
2016 | $0.600 | 0.43% |
2017 | $0.600 | 0.42% |
2018 | $0.680 | 0.35% |
2019 | $0.760 | 0.35% |
2020 | $0.880 | 0.27% |
2021 | $1.040 | 0.22% |
2022 | $1.200 | 0.19% |
2023 | $1.400 | 0.25% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend King | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Royal | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.142 | 1.500 | 7.16 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0621 | 1.200 | 7.93 | 9.51 | [0 - 0.3] |
returnOnEquityTTM | 0.133 | 1.500 | 9.63 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0897 | -1.000 | 9.10 | -9.10 | [0 - 1] |
currentRatioTTM | 1.696 | 0.800 | 6.52 | 5.22 | [1 - 3] |
quickRatioTTM | 1.192 | 0.800 | 7.70 | 6.16 | [0.8 - 2.5] |
cashRatioTTM | 0.395 | 1.500 | 8.92 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.367 | -1.500 | 3.89 | -5.83 | [0 - 0.6] |
interestCoverageTTM | 10.66 | 1.000 | 7.16 | 7.16 | [3 - 30] |
operatingCashFlowPerShareTTM | 23.37 | 2.00 | 2.21 | 4.42 | [0 - 30] |
freeCashFlowPerShareTTM | 19.79 | 2.00 | 0.105 | 0.209 | [0 - 20] |
debtEquityRatioTTM | 0.782 | -1.500 | 6.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.47 | 6.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.70 | 8.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.251 | 1.000 | 9.72 | 9.72 | [0.2 - 2] |
assetTurnoverTTM | 0.438 | 0.800 | -0.416 | -0.333 | [0.5 - 2] |
Total Score | 10.85 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.69 | 1.000 | 6.29 | 0 | [1 - 100] |
returnOnEquityTTM | 0.133 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.79 | 2.00 | 3.40 | 0.209 | [0 - 30] |
dividendYielPercentageTTM | 0.242 | 1.500 | 3.95 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 23.37 | 2.00 | 2.21 | 4.42 | [0 - 30] |
payoutRatioTTM | 0.0897 | 1.500 | 9.10 | -9.10 | [0 - 1] |
pegRatioTTM | 2.61 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.210 | 1.000 | 7.25 | 0 | [0.1 - 0.5] |
Total Score | 6.07 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators